Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[Buddhahead]

Specialty Drugs are Forecasted to be 50 Percent of All Drug Expenditures in 2018 in Compendium Blog, S. Johnson No external funding provided for this research 1
, B. Gunderson1
, K. Bowen1
, C. I. Starner1, 2
, P. P. Gleason1, 2
Prime Therapeutics, Eagan, MN, USA; 2
University of Minnesota College of Pharmacy, Minneapolis, MN, USA


Conclusions:
• Currently approximately four of five prescriptions are filled
with a generic drug at a cost of less than $20. In the coming
years, new generic drug market entrants are limited.
• Due to the increased use of generics, continued
pharmaceutical manufacturer annual double digit price
increases, increasing utilization, and future pipeline of new
specialty drugs, specialty drug expenditures are expected to
be 50 percent of all drug expenditures by 2018.
• The current top specialty category is autoimmune with the
top expenditure drug on both the medical and pharmacy
benefits. Health insurers and pharmacy benefit managers
will need to focus initially on the autoimmune category to
ensure expenditures are managed.
• Health insurers will need to increase their vigilance
of specialty drugs and focus on four management
opportunities: drug distribution channel, utilization
management, contracting activities, and coordination
of care.

Article at:
http://cdn2.content.compendiumblog.com/uploads/user/e7c690e8-6ff9-102a-ac6d-e4aebca50425/accf0d87-0d14-4aa7-bbf3-193b90c8d68c/File/1f8476cb4a60eb472893ddf381c9c3ec/prediction_that_by_2018__more_than_50_percent_of_all_drug_expenditures_will_be_specialty.pdf